Weiner P, Saaid M, Reshef A
Department of Medicine B, Rebecca Sieff Memorial Hospital, Safed, Israel.
Am Rev Respir Dis. 1988 Jun;137(6):1309-11. doi: 10.1164/ajrccm/137.6.1309.
In 21 asthmatic subjects we determined whether inhalation of an isotonic solution of disodium cromoglycate (DSCG) would result in better protection against bronchial provocation with methacholine or exercise than the standard hypotonic solution of DSCG. Pretreatment with isotonic DSCG resulted in significantly greater reduction in exercise-induced bronchospasm (10 patients) than with hypotonic DSCG. In addition, the dose of methacholine required to induce a decrease greater than 20% in FEV1 was significantly higher following pretreatment with isotonic DSCG compared with placebo or hypotonic solution of the drug (11 patients). We conclude that nebulized isotonic DSCG provides better protection against exercise- and methacholine-induced bronchoconstriction than does the standard solution. Our findings suggest that the use of an isotonic solution of DSCG would be beneficial in the management of asthmatic patients.
在21名哮喘患者中,我们确定吸入色甘酸钠二钠(DSCG)的等渗溶液是否比标准的DSCG低渗溶液能更好地预防乙酰甲胆碱或运动诱发的支气管激发。与低渗DSCG相比,等渗DSCG预处理能显著减轻运动诱发的支气管痉挛(10例患者)。此外,与安慰剂或该药物的低渗溶液相比,等渗DSCG预处理后,诱导第一秒用力呼气量(FEV1)下降超过20%所需的乙酰甲胆碱剂量显著更高(11例患者)。我们得出结论,雾化吸入等渗DSCG比标准溶液能更好地预防运动和乙酰甲胆碱诱发的支气管收缩。我们的研究结果表明,使用DSCG等渗溶液对哮喘患者的治疗有益。